Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
N/A
-42,713 Closed
0 $0
Q1 2022

May 11, 2022

BUY
N/A
2,717 Added 6.79%
42,713 $1.2 Million
Q4 2021

Feb 08, 2022

BUY
N/A
4,045 Added 11.25%
39,996 $1.09 Million
Q3 2021

Nov 02, 2021

BUY
N/A
35,951 New
35,951 $978,000
Q3 2018

Nov 14, 2018

SELL
N/A
-10,208 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
N/A
1,756 Added 20.78%
10,208 $382,000
Q1 2018

May 14, 2018

SELL
N/A
-81,822 Reduced 90.64%
8,452 $332,000
Q4 2017

Feb 14, 2018

SELL
N/A
-2,747 Reduced 2.95%
90,274 $2.93 Million
Q3 2017

Nov 13, 2017

BUY
N/A
5,264 Added 6.0%
93,021 $2.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
87,757
87,757 $2.45 Million

About Intersect ENT, Inc.


  • Ticker XENT
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,461,700
  • Market Cap $945M
More about XENT
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.